rdf:type |
|
lifeskim:mentions |
umls-concept:C0021311,
umls-concept:C0034656,
umls-concept:C0087111,
umls-concept:C0287573,
umls-concept:C0442027,
umls-concept:C0585361,
umls-concept:C0984589,
umls-concept:C1123023,
umls-concept:C1124275,
umls-concept:C1332410,
umls-concept:C1707455
|
pubmed:issue |
7
|
pubmed:dateCreated |
2002-8-16
|
pubmed:abstractText |
Uncomplicated skin and skin-structure infections are commonly observed in medical practice. Because these infections typically are confined to the superficial layers and seldom lead to the destruction of skin structures and resultant systemic dissemination, in general they can be treated with an oral antibiotic with potent microbiologic activity against gram-positive pathogens.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0149-2918
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1134-47
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12182257-Adolescent,
pubmed-meshheading:12182257-Adult,
pubmed-meshheading:12182257-Aged,
pubmed-meshheading:12182257-Aged, 80 and over,
pubmed-meshheading:12182257-Anti-Bacterial Agents,
pubmed-meshheading:12182257-Cefadroxil,
pubmed-meshheading:12182257-Cefuroxime,
pubmed-meshheading:12182257-Cephalosporins,
pubmed-meshheading:12182257-Child,
pubmed-meshheading:12182257-Double-Blind Method,
pubmed-meshheading:12182257-Drug Administration Schedule,
pubmed-meshheading:12182257-Drug Therapy, Combination,
pubmed-meshheading:12182257-Female,
pubmed-meshheading:12182257-Humans,
pubmed-meshheading:12182257-Male,
pubmed-meshheading:12182257-Middle Aged,
pubmed-meshheading:12182257-Skin Diseases, Infectious,
pubmed-meshheading:12182257-Soft Tissue Infections,
pubmed-meshheading:12182257-Treatment Outcome
|
pubmed:year |
2002
|
pubmed:articleTitle |
Randomized, double-blind, multicenter comparison of oral cefditoren 200 or 400 mg BID with either cefuroxime 250 mg BID or cefadroxil 500 mg BID for the treatment of uncomplicated skin and skin-structure infections.
|
pubmed:affiliation |
Academic Dermatology Associates, Albuquerque, New Mexico 87106-5239, USA. eatschen@aol.com
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|